301 companies
BLUE
Bluebird bio Inc
we are leading the gene therapy revolution.
Massachusetts
NASDAQ
BCLI
Brainstorm Cell Therapeutics, Inc.
brainstorm cell therapeutics inc.
New York
NASDAQ
CCCC
C4 Therapeutics Inc
c4 therapeutics is an early stage drug discovery company whose mission is to harness targeted protein degradation to develop therapeutics for a broad range of diseases.
Massachusetts
NASDAQ
CRGX
CARGO Therapeutics Inc
CARGO Therapeutics, Inc.
California
NASDAQ
CASI
CASI Pharmaceuticals Inc
CASI Pharmaceuticals, Inc.
Maryland
NASDAQ
CRSP
CRISPR Therapeutics AG
CRISPR Therapeutics is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform.
Switzerland
NASDAQ
CABA
Cabaletta Bio Inc
cabaletta bio, inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered t cell therapies for patients with b cell-mediated autoimmune diseases.
Pennsylvania
NASDAQ
CLDI
Calidi Biotherapeutics Inc - Ordinary Shares
Calidi Biotherapeutics (NYSE American: CLDI) is a clinical-stage immuno-oncology company with proprietary technology designed to arm the immune system to fight cancer.
California
NYSEAMERICAN
CADL
Candel Therapeutics Inc
also known as advantagene.
Massachusetts
NASDAQ
CBGL
Cannabis Global, Inc.
MCTC Holdings, Inc.
California
OTC
Cantab Pharmaceuticals PLC
CRDF
Cardiff Oncology Inc
trovagene is a precision medicine biotechnology company developing oncology therapeutics for improved cancer care by leveraging its proprietary precision cancer monitoring® (pcm) technology in tumor genomics.
California
NASDAQ
CRDL
Cardiol Therapeutics Inc - Ordinary Shares
cardiol therapeutics is a nanotherapeutics company focused on the research and commercial development of proprietary drug formulations for the treatment of heart failure.
Ontario, Canada
NASDAQ
CRBU
Caribou Biosciences Inc
caribou biosciences is a leading biotechnology company in genome engineering.
California
NASDAQ
CVM
Cel-Sci Corp.
cel-sci corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases.
Virginia
NYSEAMERICAN
CLLS
Cellectis
cellectis is a clinical-stage biopharmaceutical company focused on developing a new generation of cancer immunotherapies based on gene-edited t-cells (ucart). by capitalizing on its 18 years of expertise in gene editing – built on its flagship talen® technology and pioneering electroporation system pulseagile – cellectis uses the power of the immune system to target and eradicate cancer cells.
France
NASDAQ
CBMG
Cellular Biomedicine Group, Inc.
Cellular Biomedicine Group, Inc.
Maryland
NASDAQ
Centurium Capital Partners 2018, L.P.
Cayman Islands
IPSC
Century Therapeutics Inc
Century Therapeutics, Inc.
Pennsylvania
NASDAQ
CGON
Cg Oncology Inc.
California
NASDAQ